Castells, A.-A.; Balada, R.; Tristán-Noguero, A.; O’Callaghan, M.; Cortès-Saladelafont, E.; Pascual-Alonso, A.; Garcia-Cazorla, À.; Armstrong, J.; Alcántara, S.
Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy. Biomedicines 2021, 9, 148.
https://doi.org/10.3390/biomedicines9020148
AMA Style
Castells A-A, Balada R, Tristán-Noguero A, O’Callaghan M, Cortès-Saladelafont E, Pascual-Alonso A, Garcia-Cazorla À, Armstrong J, Alcántara S.
Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy. Biomedicines. 2021; 9(2):148.
https://doi.org/10.3390/biomedicines9020148
Chicago/Turabian Style
Castells, Alba-Aina, Rafel Balada, Alba Tristán-Noguero, Mar O’Callaghan, Elisenda Cortès-Saladelafont, Ainhoa Pascual-Alonso, Àngels Garcia-Cazorla, Judith Armstrong, and Soledad Alcántara.
2021. "Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy" Biomedicines 9, no. 2: 148.
https://doi.org/10.3390/biomedicines9020148
APA Style
Castells, A.-A., Balada, R., Tristán-Noguero, A., O’Callaghan, M., Cortès-Saladelafont, E., Pascual-Alonso, A., Garcia-Cazorla, À., Armstrong, J., & Alcántara, S.
(2021). Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy. Biomedicines, 9(2), 148.
https://doi.org/10.3390/biomedicines9020148